Swisspartners Ltd. Sorrento Therapeutics, Inc. Transaction History
Swisspartners Ltd.
- $78.3 Million
- Q4 2022
A detailed history of Swisspartners Ltd. transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, Swisspartners Ltd. holds 110,000 shares of SRNE stock, worth $36,300. This represents 0.12% of its overall portfolio holdings.
Number of Shares
110,000
Previous 110,000
-0.0%
Holding current value
$36,300
Previous $173,000
43.93%
% of portfolio
0.12%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding SRNE
# of Institutions
12Shares Held
5.47MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA5.22MShares$1.72 Million1.01% of portfolio
-
Lattice Capital Management, LLC51.8KShares$17,0940.02% of portfolio
-
High Point Advisor Group LLC Downers Grove, IL22.3KShares$7,3420.0% of portfolio
-
Slate Stone Wealth, LLC21.4KShares$7,0720.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO20.5KShares$6,7650.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...